Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients

Clinical trial NCT01198522 · TERMINATED

Trial details

NCT number: NCT01198522
Sponsor: Philogen S.p.A.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection

Start date: 2007-06-01
Primary completion: 2014-11-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.